Medcognetics
MedCognetics is a healthcare technology company specializing in precision artificial intelligence to transform breast cancer detection. Their flagship product, CogNet AI, is an unbiased AI platform trained on a diverse global dataset to assist radiologists by prioritizing mammograms flagged as suspicious, thereby optimizing workflow and improving diagnostic accuracy. The company addresses radiologist burnout and shortages by enabling efficient triage of mammography cases, aiming to reduce breast cancer mortality through early detection. MedCognetics has secured FDA clearance and a groundbreaking patent for its inclusive AI technology, and has received significant NIH funding to advance its research. Their business model is primarily SaaS, providing AI-enabled breast cancer screening software to radiology centers worldwide, positioning them as a leader in AI-driven women's health diagnostics with a global impact focus.
Medcognetics
MedCognetics is a healthcare technology company specializing in precision artificial intelligence to transform breast cancer detection. Their flagship product, CogNet AI, is an unbiased AI platform trained on a diverse global dataset to assist radiologists by prioritizing mammograms flagged as suspicious, thereby optimizing workflow and improving diagnostic accuracy. The company addresses radiologist burnout and shortages by enabling efficient triage of mammography cases, aiming to reduce breast cancer mortality through early detection. MedCognetics has secured FDA clearance and a groundbreaking patent for its inclusive AI technology, and has received significant NIH funding to advance its research. Their business model is primarily SaaS, providing AI-enabled breast cancer screening software to radiology centers worldwide, positioning them as a leader in AI-driven women's health diagnostics with a global impact focus.